Published 2026-09-16 · Last reviewed 2026-09-16 · By Andy Palenzuela, Founder
Nicotinamide riboside (NR) is the NAD+ precursor with the most published human pharmacokinetic data, and also the one most often explained badly — either as a miracle molecule or as "just vitamin B3." Neither is accurate. This article explains what NR is, how the body converts it to NAD+, what the three most-cited human trials actually measured (and did not), what doses they used, and how to read an NR label. It is written by the founder of Age Revive, who spent 14+ years inside regulated nutrition supply chains before formulating CELLUNAD+ around 500 mg of NR.
Nicotinamide riboside is a pyridine nucleoside — a nicotinamide ring attached to a ribose sugar. Chemically it belongs to the vitamin B3 family, alongside nicotinic acid (niacin) and nicotinamide (niacinamide). It occurs naturally in small amounts in milk and yeast.
What distinguishes NR from the other B3 forms is the route it takes to NAD+. Niacin and nicotinamide enter through pathways that involve more steps or carry side effects at high doses (niacin's flushing is the well-known example). NR is phosphorylated directly by enzymes called nicotinamide riboside kinases (NRK1 and NRK2) to nicotinamide mononucleotide (NMN), and NMN is converted to NAD+ by NMNAT enzymes. Two steps, no flushing, no nicotinamide accumulation at the front end.
The supplement form is nicotinamide riboside chloride — the salt used in all three human trials cited below.
NAD+ is not an "energy molecule" in the sense a marketer means it. It is a coenzyme — a helper that enzymes need to do their jobs — and it has two broad roles:
Tissue NAD+ levels have been reported to decline with age in a number of studies. That observation is the entire premise of the precursor category: supply more of the starting material and support NAD+ metabolism as consumption continues.
The pathway in one line: NR → NMN → NAD+.
Trammell 2016 also found something the field did not expect: after oral NR, blood levels of nicotinic acid adenine dinucleotide (NAAD) rose sharply, even though NAAD was not thought to sit on NR's route to NAD+. The authors proposed NAAD as a sensitive biomarker that NAD+ repletion is occurring. It has been used that way in NR research since.
One consequence of the back half of the pathway matters for formulation. When NAD+ is consumed, the nicotinamide released is partly cleared by an enzyme (NNMT) that spends a methyl group. That is why methylation co-factors appear in a complete NR formula — the reasoning is laid out in Should You Take TMG With NR?.
The first human pharmacokinetic study of NR. In a pilot, one healthy individual took a single 1,000 mg dose and blood NAD+ rose substantially over the following hours. In the controlled portion, twelve healthy adults took single doses of 100, 300, or 1,000 mg in a crossover design. Blood NAD+ metabolites — including NAD+, its methylated clearance products, and NAAD — rose in a dose-dependent way. No serious adverse events were reported.
What it established: oral NR is bioavailable in humans, and the response scales with dose across 100–1,000 mg.
What it did not: anything about long-term use, or any functional outcome.
A randomized, double-blind, placebo-controlled crossover in 24 healthy middle-aged and older adults (ages 55–79). Participants took 500 mg of NR twice daily — 1,000 mg/day — for six weeks, and placebo for six weeks. NR was well tolerated, and NAD+ levels in blood cells were higher during the NR phase than the placebo phase.
What it established: chronic NR at 1,000 mg/day for six weeks is well tolerated in this population and raises blood-cell NAD+.
What it did not: cognitive, energy, or performance outcomes, and nothing at 500 mg/day, which was not a study arm.
A randomized, double-blind, placebo-controlled trial in healthy overweight adults. Participants took 100, 300, or 1,000 mg of NR chloride daily, or placebo, for eight weeks. Whole-blood NAD+ increased dose-dependently and the increases were sustained through the study. NR was well tolerated at all doses, with no clinically relevant differences in adverse events versus placebo.
What it established: eight weeks of daily NR across 100–1,000 mg is well tolerated, and blood NAD+ tracks the dose.
What it did not: weight or metabolic outcomes (not the endpoints), and nothing about any finished product.
| Trial | Dose | Duration | Population | Primary finding |
|---|---|---|---|---|
| Trammell 2016 | 100 / 300 / 1,000 mg, single dose | 1 day (crossover) | 12 healthy adults | Dose-dependent rise in blood NAD+ metabolome |
| Martens 2018 | 1,000 mg/day (500 mg × 2) | 6 weeks | 24 adults, 55–79 | Well tolerated; higher blood-cell NAD+ vs placebo |
| Conze 2019 | 100 / 300 / 1,000 mg/day | 8 weeks | Healthy overweight adults | Well tolerated; dose-dependent, sustained rise in whole-blood NAD+ |
Across the published human work, NR has been studied from 100 mg to 1,000 mg per day. The lowest daily dose that produced a clear NAD+ response in Conze 2019 was 300 mg; 1,000 mg produced the largest. There is no trial that identifies an optimal dose, and no trial of 500 mg/day as a standalone arm.
CELLUNAD+ provides 500 mg of NR per daily serving (2 capsules). That is a formulation decision informed by this research: above the 300 mg floor that produced a clear response, below the 1,000 mg used in the longest-running trials, and paired with the co-factors a single-ingredient trial does not address. It is a dose informed by published human research. It is not "clinically proven" — the finished formula has not been in a trial, and we do not say otherwise.
The human trials above are the honest answer. NR chloride at up to 1,000 mg/day was well tolerated over six to eight weeks in healthy adults, including adults in their 60s and 70s, with no clinically relevant differences in adverse events from placebo. NR does not produce the flushing associated with niacin.
Two limits on that answer. First, the trials ran for weeks, not years; long-term data at supplement doses is still accumulating. Second, "well tolerated in healthy adults" is a study population, not a clearance for everyone. If you are pregnant, breastfeeding, managing a condition, or taking medication, that is a conversation with your clinician before starting any supplement.
CELLUNAD+ pairs its 500 mg of NR with TMG, 5-MTHF, methylcobalamin, and P-5-P for methylation balance, 100 mg of apigenin for CD38 pathway interest, 200 mg of R-lipoic acid for mitochondrial cofactor support, and 5 mg of BioPerine for absorption support. Non-stimulant. Every dose on the label.
What is nicotinamide riboside used for? NR is taken as an NAD+ precursor — to support NAD+ metabolism and the cellular energy chemistry NAD+ is involved in. Human trials have measured its bioavailability, its effect on blood NAD+ metabolites, and its tolerability over 6–8 weeks.
How much nicotinamide riboside should I take? Published human trials used 100 to 1,000 mg per day. Conze 2019 saw a clear NAD+ response from 300 mg/day; Martens 2018 used 1,000 mg/day. CELLUNAD+ provides 500 mg per daily serving. Any dose decision belongs with your clinician, especially alongside medication.
Is nicotinamide riboside the same as niacin? No. Both are forms of vitamin B3, but they take different routes to NAD+. Niacin causes flushing at higher doses; NR does not. NR is converted directly to NMN and then NAD+.
Does nicotinamide riboside have side effects? In the three human trials cited, NR chloride at up to 1,000 mg/day for 6–8 weeks was well tolerated, with no clinically relevant differences in adverse events versus placebo. Long-term data is still accumulating.
CELLUNAD+ product page · Science · FAQ · All Learn articles
Andy Palenzuela is the founder of Age Revive and has 14+ years of experience in regulated nutrition supply chains, including manufacturing oversight, ingredient sourcing, and quality assurance for consumer health products. Age Revive formulas are developed based on published peer-reviewed research and manufactured at cGMP-certified facilities. LinkedIn
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information in this article is for educational purposes only and is not intended as medical advice. Consult your healthcare provider before starting any supplement regimen.